Cassidy Faircloth, Pharm D, Bcop
About Cassidy Faircloth, Pharm D, Bcop
Cassidy Faircloth, Pharm D, BCOP, is the Associate Director of US Multiple Myeloma MSL Training and Strategy at Bristol Myers Squibb. She has extensive experience in hematology and oncology pharmacy practice, having held various roles at Celgene, UNC Health Care, and Duke University Hospital.
Company
Cassidy Faircloth currently works at Bristol Myers Squibb. Holding the position of Associate Director for US Multiple Myeloma MSL Training and Strategy, Cassidy plays a crucial role in developing and overseeing training programs and strategies for Medical Science Liaisons (MSLs) focused on multiple myeloma.
Previous Experience at Celgene
Cassidy Faircloth previously worked at Celgene, where she held different roles at distinct times. From 2019 to 2020, she served as a Medical Science Liaison in the Raleigh-Durham, North Carolina Area. Furthermore, in 2008, she interned as a Pharmacist in the Global Manufacturing Quality Assurance Group for three months in Overland Park, Kansas.
Clinical Practice at UNC Health Care
For six years, from 2013 to 2019, Cassidy Faircloth served as a Clinical Pharmacy Practitioner specializing in Pediatric Hematology/Oncology/Stem Cell Transplant at UNC Health Care in Chapel Hill, North Carolina. During this time, she was deeply involved in clinical practice, focusing on pediatric patients undergoing hematology, oncology, and stem cell transplant treatments.
Role at Duke University Hospital
Between 2011 and 2013, Cassidy Faircloth worked as a Pediatric Clinical Pharmacist at Duke University Hospital in Durham, North Carolina. In this role, she was responsible for the pharmacological care of pediatric patients, leveraging her expertise in clinical pharmacy.
Education and Training
Cassidy Faircloth has a comprehensive educational background, including a Doctor of Pharmacy (PharmD) degree from the University of Missouri-Kansas City, which she completed in 2009. Following this, she pursued residencies with a focus on hematology and oncology. She completed a Hospital Pharmacy Practice Residency with an emphasis in Hematology/Oncology at Scott & White Memorial Hospital (2009-2010) and a Hospital Pharmacy Hematology/Oncology Practice Residency at Mayo Clinic in Rochester, Minnesota (2010-2011). Her foundational studies were done at Truman State University, focusing on Pre-Pharmacy Studies from 2002 to 2004.